CLEVELAND, March 13, 2009 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Cowen and Company 29th Annual Health Care Conference, to be held March 16-19, 2009, at The Boston Marriott Copley Place.
William (B.J.) Lehmann, President and Chief Operating Officer, will present on Tuesday, March 17th, at 2:25 PM (Eastern Daylight Savings Time). Investors may listen to a live audio web cast of Athersys' presentation by accessing the following link: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ATHX&item_id=2110968
A web cast replay of the presentation can be accessed via the company's web site at: www.athersys.com, under the Investors section.
About Athersys, Inc.
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing MultiStem, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. The Company is also developing a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). More information is available at www.athersys.com.
The Athersys, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4548